Medical Devices & Consumables
Global NK Cell Therapy Market Research Report 2025
- Sep 09, 25
- ID: 204659
- Pages: 86
- Figures: 84
- Views: 8
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
ImmunityBio, Inc
GC Cell
Affimed
Innate Pharma SA
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Nkarta Therapeutics
Fortress Biotech
Nkure
Segment by Type
NK Cell Therapy
CAR-NK Cell Therapy
Segment by Application
Cancer
Infectious Diseases
Gastrointestinal Diseases
Beauty and Anti-Aging
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nektar Therapeutics
ImmunityBio, Inc
GC Cell
Affimed
Innate Pharma SA
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Nkarta Therapeutics
Fortress Biotech
Nkure
Segment by Type
NK Cell Therapy
CAR-NK Cell Therapy
Segment by Application
Cancer
Infectious Diseases
Gastrointestinal Diseases
Beauty and Anti-Aging
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapy
1.2.3 CAR-NK Cell Therapy
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Gastrointestinal Diseases
1.3.5 Beauty and Anti-Aging
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2020-2031)
2.2 Global NK Cell Therapy Growth Trends by Region
2.2.1 Global NK Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NK Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top NK Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2024
3.5 Global Key Players of NK Cell Therapy Head office and Area Served
3.6 Global Key Players of NK Cell Therapy, Product and Application
3.7 Global Key Players of NK Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2026-2031)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NK Cell Therapy Market Size (2020-2031)
6.2 North America NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NK Cell Therapy Market Size by Country (2020-2025)
6.4 North America NK Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2020-2031)
7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NK Cell Therapy Market Size by Country (2020-2025)
7.4 Europe NK Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2020-2031)
9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NK Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America NK Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.1.5 Nektar Therapeutics Recent Development
11.2 ImmunityBio, Inc
11.2.1 ImmunityBio, Inc Company Details
11.2.2 ImmunityBio, Inc Business Overview
11.2.3 ImmunityBio, Inc NK Cell Therapy Introduction
11.2.4 ImmunityBio, Inc Revenue in NK Cell Therapy Business (2020-2025)
11.2.5 ImmunityBio, Inc Recent Development
11.3 GC Cell
11.3.1 GC Cell Company Details
11.3.2 GC Cell Business Overview
11.3.3 GC Cell NK Cell Therapy Introduction
11.3.4 GC Cell Revenue in NK Cell Therapy Business (2020-2025)
11.3.5 GC Cell Recent Development
11.4 Affimed
11.4.1 Affimed Company Details
11.4.2 Affimed Business Overview
11.4.3 Affimed NK Cell Therapy Introduction
11.4.4 Affimed Revenue in NK Cell Therapy Business (2020-2025)
11.4.5 Affimed Recent Development
11.5 Innate Pharma SA
11.5.1 Innate Pharma SA Company Details
11.5.2 Innate Pharma SA Business Overview
11.5.3 Innate Pharma SA NK Cell Therapy Introduction
11.5.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2020-2025)
11.5.5 Innate Pharma SA Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Details
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics NK Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.6.5 Fate Therapeutics Recent Development
11.7 Glycostem Therapeutics
11.7.1 Glycostem Therapeutics Company Details
11.7.2 Glycostem Therapeutics Business Overview
11.7.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.7.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.7.5 Glycostem Therapeutics Recent Development
11.8 Dragonfly Therapeutics
11.8.1 Dragonfly Therapeutics Company Details
11.8.2 Dragonfly Therapeutics Business Overview
11.8.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.8.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.8.5 Dragonfly Therapeutics Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Details
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.9.5 Nkarta Therapeutics Recent Development
11.10 Fortress Biotech
11.10.1 Fortress Biotech Company Details
11.10.2 Fortress Biotech Business Overview
11.10.3 Fortress Biotech NK Cell Therapy Introduction
11.10.4 Fortress Biotech Revenue in NK Cell Therapy Business (2020-2025)
11.10.5 Fortress Biotech Recent Development
11.11 Nkure
11.11.1 Nkure Company Details
11.11.2 Nkure Business Overview
11.11.3 Nkure NK Cell Therapy Introduction
11.11.4 Nkure Revenue in NK Cell Therapy Business (2020-2025)
11.11.5 Nkure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapy
1.2.3 CAR-NK Cell Therapy
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Gastrointestinal Diseases
1.3.5 Beauty and Anti-Aging
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2020-2031)
2.2 Global NK Cell Therapy Growth Trends by Region
2.2.1 Global NK Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NK Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top NK Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2024
3.5 Global Key Players of NK Cell Therapy Head office and Area Served
3.6 Global Key Players of NK Cell Therapy, Product and Application
3.7 Global Key Players of NK Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2026-2031)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NK Cell Therapy Market Size (2020-2031)
6.2 North America NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NK Cell Therapy Market Size by Country (2020-2025)
6.4 North America NK Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2020-2031)
7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NK Cell Therapy Market Size by Country (2020-2025)
7.4 Europe NK Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2020-2031)
9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NK Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America NK Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.1.5 Nektar Therapeutics Recent Development
11.2 ImmunityBio, Inc
11.2.1 ImmunityBio, Inc Company Details
11.2.2 ImmunityBio, Inc Business Overview
11.2.3 ImmunityBio, Inc NK Cell Therapy Introduction
11.2.4 ImmunityBio, Inc Revenue in NK Cell Therapy Business (2020-2025)
11.2.5 ImmunityBio, Inc Recent Development
11.3 GC Cell
11.3.1 GC Cell Company Details
11.3.2 GC Cell Business Overview
11.3.3 GC Cell NK Cell Therapy Introduction
11.3.4 GC Cell Revenue in NK Cell Therapy Business (2020-2025)
11.3.5 GC Cell Recent Development
11.4 Affimed
11.4.1 Affimed Company Details
11.4.2 Affimed Business Overview
11.4.3 Affimed NK Cell Therapy Introduction
11.4.4 Affimed Revenue in NK Cell Therapy Business (2020-2025)
11.4.5 Affimed Recent Development
11.5 Innate Pharma SA
11.5.1 Innate Pharma SA Company Details
11.5.2 Innate Pharma SA Business Overview
11.5.3 Innate Pharma SA NK Cell Therapy Introduction
11.5.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2020-2025)
11.5.5 Innate Pharma SA Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Details
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics NK Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.6.5 Fate Therapeutics Recent Development
11.7 Glycostem Therapeutics
11.7.1 Glycostem Therapeutics Company Details
11.7.2 Glycostem Therapeutics Business Overview
11.7.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.7.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.7.5 Glycostem Therapeutics Recent Development
11.8 Dragonfly Therapeutics
11.8.1 Dragonfly Therapeutics Company Details
11.8.2 Dragonfly Therapeutics Business Overview
11.8.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.8.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.8.5 Dragonfly Therapeutics Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Details
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2020-2025)
11.9.5 Nkarta Therapeutics Recent Development
11.10 Fortress Biotech
11.10.1 Fortress Biotech Company Details
11.10.2 Fortress Biotech Business Overview
11.10.3 Fortress Biotech NK Cell Therapy Introduction
11.10.4 Fortress Biotech Revenue in NK Cell Therapy Business (2020-2025)
11.10.5 Fortress Biotech Recent Development
11.11 Nkure
11.11.1 Nkure Company Details
11.11.2 Nkure Business Overview
11.11.3 Nkure NK Cell Therapy Introduction
11.11.4 Nkure Revenue in NK Cell Therapy Business (2020-2025)
11.11.5 Nkure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapy
Table 3. Key Players of CAR-NK Cell Therapy
Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NK Cell Therapy Market Share by Region (2020-2025)
Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NK Cell Therapy Market Share by Region (2026-2031)
Table 10. NK Cell Therapy Market Trends
Table 11. NK Cell Therapy Market Drivers
Table 12. NK Cell Therapy Market Challenges
Table 13. NK Cell Therapy Market Restraints
Table 14. Global NK Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NK Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NK Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of NK Cell Therapy, Product and Application
Table 21. Global Key Players of NK Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NK Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NK Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NK Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global NK Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NK Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NK Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NK Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NK Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Nektar Therapeutics Company Details
Table 47. Nektar Therapeutics Business Overview
Table 48. Nektar Therapeutics NK Cell Therapy Product
Table 49. Nektar Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Nektar Therapeutics Recent Development
Table 51. ImmunityBio, Inc Company Details
Table 52. ImmunityBio, Inc Business Overview
Table 53. ImmunityBio, Inc NK Cell Therapy Product
Table 54. ImmunityBio, Inc Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. ImmunityBio, Inc Recent Development
Table 56. GC Cell Company Details
Table 57. GC Cell Business Overview
Table 58. GC Cell NK Cell Therapy Product
Table 59. GC Cell Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. GC Cell Recent Development
Table 61. Affimed Company Details
Table 62. Affimed Business Overview
Table 63. Affimed NK Cell Therapy Product
Table 64. Affimed Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Affimed Recent Development
Table 66. Innate Pharma SA Company Details
Table 67. Innate Pharma SA Business Overview
Table 68. Innate Pharma SA NK Cell Therapy Product
Table 69. Innate Pharma SA Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Innate Pharma SA Recent Development
Table 71. Fate Therapeutics Company Details
Table 72. Fate Therapeutics Business Overview
Table 73. Fate Therapeutics NK Cell Therapy Product
Table 74. Fate Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Fate Therapeutics Recent Development
Table 76. Glycostem Therapeutics Company Details
Table 77. Glycostem Therapeutics Business Overview
Table 78. Glycostem Therapeutics NK Cell Therapy Product
Table 79. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Glycostem Therapeutics Recent Development
Table 81. Dragonfly Therapeutics Company Details
Table 82. Dragonfly Therapeutics Business Overview
Table 83. Dragonfly Therapeutics NK Cell Therapy Product
Table 84. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Dragonfly Therapeutics Recent Development
Table 86. Nkarta Therapeutics Company Details
Table 87. Nkarta Therapeutics Business Overview
Table 88. Nkarta Therapeutics NK Cell Therapy Product
Table 89. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Nkarta Therapeutics Recent Development
Table 91. Fortress Biotech Company Details
Table 92. Fortress Biotech Business Overview
Table 93. Fortress Biotech NK Cell Therapy Product
Table 94. Fortress Biotech Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Fortress Biotech Recent Development
Table 96. Nkure Company Details
Table 97. Nkure Business Overview
Table 98. Nkure NK Cell Therapy Product
Table 99. Nkure Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Nkure Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. NK Cell Therapy Picture
Figure 2. Global NK Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NK Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapy Features
Figure 5. CAR-NK Cell Therapy Features
Figure 6. Global NK Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NK Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Gastrointestinal Diseases Case Studies
Figure 11. Beauty and Anti-Aging Case Studies
Figure 12. Others Case Studies
Figure 13. NK Cell Therapy Report Years Considered
Figure 14. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global NK Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global NK Cell Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global NK Cell Therapy Market Share by Players in 2024
Figure 18. Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2024
Figure 20. North America NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America NK Cell Therapy Market Share by Country (2020-2031)
Figure 22. United States NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe NK Cell Therapy Market Share by Country (2020-2031)
Figure 26. Germany NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific NK Cell Therapy Market Share by Region (2020-2031)
Figure 34. China NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America NK Cell Therapy Market Share by Country (2020-2031)
Figure 42. Mexico NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa NK Cell Therapy Market Share by Country (2020-2031)
Figure 46. Israel NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 50. ImmunityBio, Inc Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 51. GC Cell Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 52. Affimed Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 53. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 54. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 55. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 56. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 57. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 58. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 59. Nkure Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapy
Table 3. Key Players of CAR-NK Cell Therapy
Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NK Cell Therapy Market Share by Region (2020-2025)
Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NK Cell Therapy Market Share by Region (2026-2031)
Table 10. NK Cell Therapy Market Trends
Table 11. NK Cell Therapy Market Drivers
Table 12. NK Cell Therapy Market Challenges
Table 13. NK Cell Therapy Market Restraints
Table 14. Global NK Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NK Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NK Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of NK Cell Therapy, Product and Application
Table 21. Global Key Players of NK Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NK Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NK Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NK Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global NK Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NK Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NK Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NK Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NK Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NK Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NK Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NK Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Nektar Therapeutics Company Details
Table 47. Nektar Therapeutics Business Overview
Table 48. Nektar Therapeutics NK Cell Therapy Product
Table 49. Nektar Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Nektar Therapeutics Recent Development
Table 51. ImmunityBio, Inc Company Details
Table 52. ImmunityBio, Inc Business Overview
Table 53. ImmunityBio, Inc NK Cell Therapy Product
Table 54. ImmunityBio, Inc Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. ImmunityBio, Inc Recent Development
Table 56. GC Cell Company Details
Table 57. GC Cell Business Overview
Table 58. GC Cell NK Cell Therapy Product
Table 59. GC Cell Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. GC Cell Recent Development
Table 61. Affimed Company Details
Table 62. Affimed Business Overview
Table 63. Affimed NK Cell Therapy Product
Table 64. Affimed Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Affimed Recent Development
Table 66. Innate Pharma SA Company Details
Table 67. Innate Pharma SA Business Overview
Table 68. Innate Pharma SA NK Cell Therapy Product
Table 69. Innate Pharma SA Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Innate Pharma SA Recent Development
Table 71. Fate Therapeutics Company Details
Table 72. Fate Therapeutics Business Overview
Table 73. Fate Therapeutics NK Cell Therapy Product
Table 74. Fate Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Fate Therapeutics Recent Development
Table 76. Glycostem Therapeutics Company Details
Table 77. Glycostem Therapeutics Business Overview
Table 78. Glycostem Therapeutics NK Cell Therapy Product
Table 79. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Glycostem Therapeutics Recent Development
Table 81. Dragonfly Therapeutics Company Details
Table 82. Dragonfly Therapeutics Business Overview
Table 83. Dragonfly Therapeutics NK Cell Therapy Product
Table 84. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Dragonfly Therapeutics Recent Development
Table 86. Nkarta Therapeutics Company Details
Table 87. Nkarta Therapeutics Business Overview
Table 88. Nkarta Therapeutics NK Cell Therapy Product
Table 89. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Nkarta Therapeutics Recent Development
Table 91. Fortress Biotech Company Details
Table 92. Fortress Biotech Business Overview
Table 93. Fortress Biotech NK Cell Therapy Product
Table 94. Fortress Biotech Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Fortress Biotech Recent Development
Table 96. Nkure Company Details
Table 97. Nkure Business Overview
Table 98. Nkure NK Cell Therapy Product
Table 99. Nkure Revenue in NK Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Nkure Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. NK Cell Therapy Picture
Figure 2. Global NK Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NK Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapy Features
Figure 5. CAR-NK Cell Therapy Features
Figure 6. Global NK Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NK Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Gastrointestinal Diseases Case Studies
Figure 11. Beauty and Anti-Aging Case Studies
Figure 12. Others Case Studies
Figure 13. NK Cell Therapy Report Years Considered
Figure 14. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global NK Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global NK Cell Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global NK Cell Therapy Market Share by Players in 2024
Figure 18. Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2024
Figure 20. North America NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America NK Cell Therapy Market Share by Country (2020-2031)
Figure 22. United States NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe NK Cell Therapy Market Share by Country (2020-2031)
Figure 26. Germany NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific NK Cell Therapy Market Share by Region (2020-2031)
Figure 34. China NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America NK Cell Therapy Market Share by Country (2020-2031)
Figure 42. Mexico NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa NK Cell Therapy Market Share by Country (2020-2031)
Figure 46. Israel NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE NK Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 50. ImmunityBio, Inc Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 51. GC Cell Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 52. Affimed Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 53. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 54. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 55. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 56. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 57. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 58. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 59. Nkure Revenue Growth Rate in NK Cell Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232